← Back to All Filings

Encompass Health Director Nancy M. Schlichting Receives Dividend-Equivalent RSUs

Low SignificanceOctober 19, 2026 at 4:10:48 PM EDT

Encompass Health Corp

$EHC4CIK: 0000785161

Subscribe to track EHC

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📋 Form 4 Filing: Encompass Health Corp ($EHC) Insider: Nancy M. Schlichting (Director) Transaction Date: October 15, 2026 Type: Acquisition (Award) | Code: A Shares: 38 @ $0.00 Post-Transaction Holdings: 23,010 shares Note: Dividend equivalent restricted stock units credited pursuant to outstanding RSU award agreements.

Comprehensive Analysis

Transaction Overview

On October 15, 2026, Nancy M. Schlichting, a member of the Board of Directors of Encompass Health Corp ($EHC), acquired 38 shares of Encompass Health Common Stock (in the form of Restricted Stock Units) at an acquisition price of $0.00 per share.

Key Details

  • Security: Encompass Health Common Stock
  • Shares Acquired: 38
  • Transaction Price: $0.00
  • Total Beneficial Ownership Following Transaction: 23,010 shares (held directly)
  • Transaction Code: A (Grant, award, or other acquisition)

Context & Significance

According to footnote disclosure, the 38 RSUs were automatically credited to Director Schlichting's account in connection with the company's regular quarterly common stock dividend of $0.21 per share paid on October 15, 2026 (based on a closing stock price of $127.77). This represents routine dividend reinvestment on outstanding RSU awards under non-employee director compensation terms rather than discretionary open-market buying or selling. Consequently, the trading significance is categorized as Low.

Topics:#EHC#EncompassHealth#InsiderTrading#Form4#CorporateGovernance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.